Drug approvals

Valbenazine is indicated for the treatment of tardive dyskinesia (uncontrollable movement of face, tongue, or other body parts)

With this approval, Glenmark is eligible for 180-days of generic drug exclusivity for Calcipotriene and Betamethasone Dipropionate…

Glenmark’s current portfolio consists of 182 products authorised for distribution in the US marketplace

Ranolazine ER tablets are indicated for the treatment of chronic angina

A humanised IgG4 monoclonal antibody, Copellor (Ixekizumab) is designed to specifically target IL-17A, a protein that plays a role…

Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (US FDA) for…

USFDA accepts Eisai's sBLA and grants priority review for approval of LEQEMBITM Alzheimer's treatment

It is indicated for the treatment of patients with adenocarcinoma of colon and rectum, adenocarcinoma of the breast, gastric…

Vigabatrin for oral solution is indicated for the treatment of refractory complex partial seizures as adjunctive therapy in…

Rocuronium Bromide Injection is a neuromuscular blocking agent, indicated as an adjunct to general anesthesia to facilitate both…